X0202 SCHEDULE 13G/A 0000902664-26-001154 0002024579 XXXXXXXX LIVE 1 Common Stock, $0.00001 par value per share 03/31/2026 0001800315 Damora Therapeutics, Inc. 36322Q206 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 Rule 13d-1(b) Jain Global LLC DE 0.00 0.00 0.00 0.00 0.00 N 0 IA OO Jain Holdings LLC DE 0.00 0.00 0.00 0.00 0.00 N 0 HC OO Robert Jain X1 0.00 0.00 0.00 0.00 0.00 N 0 HC IN Damora Therapeutics, Inc. 221 Crescent Street, Building 23, Suite 105, Waltham, Massachusetts 02453 This Schedule 13G is being jointly filed by Jain Global LLC ("Jain Global"), a registered investment adviser, Jain Holdings LLC ("Jain Holdings"), and Mr. Robert Jain (collectively with Jain Global and Jain Holdings, the "Reporting Persons") with respect to the common stock, $0.00001 par value per share ("Shares"), of Damora Therapeutics, Inc. (the "Company") owned by Jain Global Master Fund Ltd (the "Fund"). Jain Global is the investment manager for the Fund. Jain Holdings is the sole member of Jain Global. Mr. Jain is the Chief Executive Officer and Chief Investment Officer of Jain Global, and owns a controlling interest in Jain Holdings. This Schedule 13G shall not be construed as an admission by the Reporting Persons that they are the beneficial owners of any of the Shares covered by this Schedule 13G. The address of each of the Reporting Persons is 9 West 57th Street, 39th Floor, New York, New York, 10019. Each of Jain Global and Jain Holdings is organized as a limited liability company under the laws of the State of Delaware. Mr. Jain is a U.S. citizen. N IA HC The information required by Item 4(a) is set forth in Row 9 of the cover page for each of the Reporting Persons and is incorporated herein by reference. 0.0% The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference. The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference. N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Jain Global LLC /s/ Noah Goldberg 05/15/2026 Jain Holdings LLC /s/ Noah Goldberg 05/15/2026 Robert Jain /s/ Noah Goldberg 05/15/2026 *Noah Goldberg is signing on behalf of Robert Jain as attorney-in-fact pursuant to a power of attorney previously filed with the Securities and Exchange Commission and hereby incorporated by reference herein. The power of attorney was filed as an attachment to a filing by Jain Global LLC on Schedule 13G for the Company (then Galecto, Inc.) on February 17, 2026.